PSUSA/00002698/202501

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Rabitec, rabies vaccine (live, oral) for foxes and raccoon dogs, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Isturisa, Osilodrostat, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: P/0325/2024

Human medicines European public assessment report (EPAR): Bortezomib Sun, bortezomib, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Nulojix, belatacept, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0351/2024

Veterinary medicines European public assessment report (EPAR): Ubac, Streptococcus uberis vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Tulissin, tulathromycin, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Tulinovet, tulathromycin, Status: Authorised

Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 12, Status: Authorised